Total Payments
$909.60
2024 Payments
$635.07
Companies
5
Transactions
32
Medicare Patients
880
Medicare Billing
$45,848
Payment Breakdown by Category
Food & Beverage$909.60 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $909.60 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $328.59 | 15 | $0 (2024) |
| Lilly USA, LLC | $170.10 | 2 | $0 (2024) |
| ABBVIE INC. | $142.40 | 4 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $139.22 | 4 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $129.29 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $635.07 | 21 | Novo Nordisk Inc ($183.35) |
| 2022 | $274.53 | 11 | Novo Nordisk Inc ($145.24) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: Obesity | ||||||
| 11/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $3.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: Obesity | ||||||
| 08/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: Obesity | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: Obesity | ||||||
| 07/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Obesity | ||||||
| 07/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: Obesity | ||||||
| 05/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: Obesity | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: Obesity | ||||||
| 03/28/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $94.50 | General |
| Category: Obesity | ||||||
| 03/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: Obesity | ||||||
| 03/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $75.60 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: Obesity | ||||||
| 01/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: Obesity | ||||||
| 12/16/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: Obesity | ||||||
| 11/16/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: PRIMARY CARE | ||||||
| 11/04/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Obesity | ||||||
| 11/01/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 201 | 242 | $48,568 | $12,079 |
| 2022 | 7 | 221 | 295 | $51,535 | $12,104 |
| 2021 | 7 | 195 | 255 | $44,072 | $9,776 |
| 2020 | 10 | 263 | 370 | $60,793 | $11,889 |
Total Patients
880
Total Services
1,162
Medicare Billing
$45,848
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 65 | $19,917 | $4,115 | 20.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $9,212 | $2,891 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $7,828 | $1,976 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 24 | $4,968 | $1,163 | 23.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 12 | 12 | $3,180 | $863.16 | 27.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 54 | 65 | $1,125 | $546.00 | 48.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $1,170 | $371.80 | 31.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 16 | $1,168 | $152.32 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 95 | $28,975 | $5,919 | 20.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $9,212 | $2,947 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 29 | $6,003 | $1,426 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $4,944 | $1,344 | 27.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 66 | 97 | $873.00 | $284.96 | 32.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 12 | 16 | $1,168 | $143.73 | 12.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 14 | 18 | $360.00 | $39.95 | 11.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 84 | $25,620 | $5,344 | 20.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 16 | 16 | $5,264 | $1,714 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 31 | $6,417 | $1,336 | 20.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $4,532 | $948.91 | 20.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 52 | 79 | $711.00 | $237.00 | 33.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 11 | 16 | $1,168 | $155.36 | 13.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 18 | 18 | $360.00 | $40.50 | 11.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 83 | 133 | $40,605 | $6,958 | 17.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 21 | 21 | $6,909 | $1,826 | 26.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 25 | $5,190 | $1,054 | 20.3% |
About Dava Helton, APRN
Dava Helton, APRN is a Family healthcare provider based in Clarksville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2017. The National Provider Identifier (NPI) number assigned to this provider is 1649711698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dava Helton, APRN has received a total of $909.60 in payments from pharmaceutical and medical device companies, with $635.07 received in 2024. These payments were reported across 32 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($909.60).
As a Medicare-enrolled provider, Helton has provided services to 880 Medicare beneficiaries, totaling 1,162 services with total Medicare billing of $45,848. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Clarksville, IN
- Active Since 03/10/2017
- Last Updated 08/28/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1649711698
Products in Payments
- Wegovy (Drug) $183.35
- Saxenda (Drug) $145.24
- VRAYLAR (Drug) $142.40
- VOQUEZNA (Drug) $139.22
- NURTEC ODT (Drug) $129.29
- ZEPBOUND (Drug) $94.50
- MOUNJARO (Drug) $75.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Clarksville
Rhonda Hettinger, Np, NP
Family — Payments: $35,080
Family $35,080
Kayla Teives, Np-C, NP-C
Family — Payments: $8,369
Family $8,369
Danielle Conroy, Np, NP
Family — Payments: $5,696
Family $5,696
Mrs. Terry Holt, Fnp, FNP
Family — Payments: $4,648
Family $4,648
Mrs. Carrie Hinton, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $4,601
Family $4,601
Charlsie Deloach, Fnp-Cb, FNP-CB
Family — Payments: $4,589
Family $4,589